Transition Therapeutics (NASDAQ: TTHI) recorded a net loss of $16,119,202 ($0.70 per common share) compared to a net loss of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE